Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BBNX Beta Bionics	$14.89 -6.2%	$15.31	$8.89 ▼ $24.50	$647.27M	N/A	523,091 shs	295,772 shs
INSP Inspire Medical Systems	$91.78 +1.9%	$119.71	$73.92 ▼ $225.00	$2.71B	1.22	680,325 shs	530,043 shs
LQDA Liquidia Technologies	$27.04 -0.3%	$16.74	$8.75 ▼ $28.00	$2.33B	0.14	1.78 million shs	1.47 million shs
PRCT PROCEPT BioRobotics	$39.21 -1.3%	$53.87	$37.12 ▼ $103.81	$2.18B	1.05	1.02 million shs	336,123 shs

10 Best Stocks to Own: Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BBNX Beta Bionics	-8.00%	+11.67%	+16.85%	+2.06%	+1,587,999,900.00%
INSP Inspire Medical Systems	+1.95%	+6.98%	-29.10%	-38.51%	-53.57%
LQDA Liquidia Technologies	-2.20%	+12.49%	+86.45%	+62.73%	+176.92%
PRCT PROCEPT BioRobotics	-2.43%	+2.90%	-31.93%	-29.87%	-39.44%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BBNX Beta Bionics	2.7911 of 5 stars	4.4	0.0	0.0	3.2	0.8	0.0
INSP Inspire Medical Systems	4.9247 of 5 stars	4.3	4.0	4.8	3.8	1.7	1.9
LQDA Liquidia Technologies	3.4769 of 5 stars	3.5	3.0	0.0	2.8	4.2	0.6
PRCT PROCEPT BioRobotics	3.4924 of 5 stars	4.4	1.0	0.0	3.1	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BBNX Beta Bionics	2.75	Moderate Buy	$22.56	51.48% Upside
INSP Inspire Medical Systems	2.54	Moderate Buy	$165.62	80.46% Upside
LQDA Liquidia Technologies	3.00	Buy	$32.11	18.75% Upside
PRCT PROCEPT BioRobotics	2.78	Moderate Buy	$74.88	90.94% Upside

Current Analyst Ratings Breakdown

Latest BBNX, INSP, PRCT, and LQDA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/15/2025	INSP Inspire Medical Systems	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$116.00 ➝ $97.00
8/15/2025	LQDA Liquidia Technologies	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$43.00
8/13/2025	LQDA Liquidia Technologies	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Strong-Buy ➝ Strong-Buy	$33.00 ➝ $41.00
8/13/2025	LQDA Liquidia Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$25.00 ➝ $31.00
8/12/2025	LQDA Liquidia Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$32.00 ➝ $36.00
8/7/2025	PRCT PROCEPT BioRobotics	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$75.00 ➝ $58.00
8/7/2025	PRCT PROCEPT BioRobotics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $55.00
8/5/2025	INSP Inspire Medical Systems	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$270.00 ➝ $150.00
8/5/2025	INSP Inspire Medical Systems	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$174.00 ➝ $101.00
8/5/2025	INSP Inspire Medical Systems	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$270.00 ➝ $230.00
8/5/2025	INSP Inspire Medical Systems	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$215.00 ➝ $180.00

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BBNX Beta Bionics	$78.02M	8.30	N/A	N/A	$6.94 per share	2.15
INSP Inspire Medical Systems	$802.80M	3.38	$1.77 per share	51.71	$22.92 per share	4.00
LQDA Liquidia Technologies	$14M	166.28	N/A	N/A	$0.18 per share	150.22
PRCT PROCEPT BioRobotics	$224.50M	9.72	N/A	N/A	$6.93 per share	5.66

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BBNX Beta Bionics	-$54.76M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	$53.51M	$1.73	53.05	28.50	2.76	6.17%	10.38%	8.93%	11/3/2025 (Estimated)
LQDA Liquidia Technologies	-$130.39M	-$1.70	N/A	N/A	N/A	-732.17%	-232.96%	-60.81%	N/A
PRCT PROCEPT BioRobotics	-$91.41M	-$1.55	N/A	N/A	N/A	-30.60%	-23.73%	-17.34%	10/27/2025 (Estimated)

Latest BBNX, INSP, PRCT, and LQDA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	LQDA Liquidia Technologies	-$0.43	-$0.49	-$0.06	-$0.49	$3.90 million	$8.84 million
8/6/2025	Q2 2025	PRCT PROCEPT BioRobotics	-$0.41	-$0.35	+$0.06	-$0.35	$75.67 million	$79.18 million
8/4/2025	Q2 2025	INSP Inspire Medical Systems	$0.22	$0.45	+$0.23	-$0.12	$214.50 million	$217.09 million
7/29/2025	Q2 2025	BBNX Beta Bionics	-$0.51	-$0.39	+$0.12	-$0.39	$19.73 million	$23.24 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BBNX Beta Bionics	N/A	N/A	N/A	N/A	N/A
INSP Inspire Medical Systems	N/A	N/A	N/A	N/A	N/A
LQDA Liquidia Technologies	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BBNX Beta Bionics	N/A	14.68	13.79
INSP Inspire Medical Systems	N/A	6.14	4.84
LQDA Liquidia Technologies	9.84	2.49	2.41
PRCT PROCEPT BioRobotics	0.13	9.21	7.86

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BBNX Beta Bionics	N/A
INSP Inspire Medical Systems	94.91%
LQDA Liquidia Technologies	64.54%
PRCT PROCEPT BioRobotics	89.46%

Insider Ownership

Company	Insider Ownership
BBNX Beta Bionics	N/A
INSP Inspire Medical Systems	2.30%
LQDA Liquidia Technologies	30.10%
PRCT PROCEPT BioRobotics	17.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BBNX Beta Bionics	294	43.47 million	N/A	N/A
INSP Inspire Medical Systems	1,246	29.57 million	28.89 million	Optionable
LQDA Liquidia Technologies	50	86.09 million	60.18 million	Optionable
PRCT PROCEPT BioRobotics	430	55.64 million	45.96 million	Optionable

BBNX, INSP, PRCT, and LQDA Headlines

Recent News About These Companies

PROCEPT BioRobotics Corporation $PRCT Holdings Trimmed by Vanguard Group Inc.

August 19 at 3:46 AM | marketbeat.com

Sit Investment Associates Inc. Raises Stake in PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

August 18 at 5:19 AM | marketbeat.com

Deutsche Bank AG Cuts Stock Position in PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

August 18 at 3:37 AM | marketbeat.com

Sei Investments Co. Sells 8,550 Shares of PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

August 17 at 5:59 AM | marketbeat.com

Lord Abbett & CO. LLC Decreases Holdings in PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

August 17 at 5:49 AM | marketbeat.com

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Moderate Buy" from Brokerages

August 17 at 3:15 AM | marketbeat.com

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Moderate Buy" from Analysts

August 16, 2025 | americanbankingnews.com

Entropy Technologies LP Acquires Shares of 7,100 PROCEPT BioRobotics Corporation (NASDAQ:PRCT)

August 15, 2025 | marketbeat.com

Procept BioRobotics director buys 785K in common stock

August 15, 2025 | msn.com

Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy

August 14, 2025 | seekingalpha.com

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

August 14, 2025 | marketbeat.com

Leerink Partners Reiterates a Buy Rating on PROCEPT BioRobotics (PRCT)

August 13, 2025 | msn.com

Leerink Partnrs Issues Pessimistic Outlook for PRCT Earnings

August 12, 2025 | americanbankingnews.com

William Blair Issues Pessimistic Outlook for PRCT Earnings

August 12, 2025 | americanbankingnews.com

PROCEPT BioRobotics (NASDAQ:PRCT) Stock Rating Upgraded by Wall Street Zen

August 11, 2025 | americanbankingnews.com

Leerink Partnrs Has Negative Forecast for PRCT Q3 Earnings

August 11, 2025 | marketbeat.com

William Blair Issues Negative Forecast for PRCT Earnings

August 11, 2025 | marketbeat.com

PROCEPT BioRobotics (NASDAQ:PRCT) Upgraded to "Hold" at Wall Street Zen

August 10, 2025 | marketbeat.com

PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q2 2025 Earnings Call Transcript

August 8, 2025 | msn.com

PROCEPT BioRobotics (NASDAQ:PRCT) Price Target Lowered to $58.00 at Wells Fargo & Company

August 8, 2025 | marketbeat.com

PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Down on Analyst Downgrade

August 8, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BBNX, INSP, PRCT, and LQDA Company Descriptions

Beta Bionics NASDAQ:BBNX

$14.89 -0.99 (-6.23%)

As of 02:25 PM Eastern

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Inspire Medical Systems NYSE:INSP

$91.78 +1.72 (+1.90%)

As of 02:45 PM Eastern

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Liquidia Technologies NASDAQ:LQDA

$27.04 -0.07 (-0.26%)

As of 02:45 PM Eastern

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

PROCEPT BioRobotics NASDAQ:PRCT

$39.21 -0.51 (-1.28%)

As of 02:45 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time